Diagnosis and treatment of sarcopenia in patients undergoing peritoneal dialysis
10.3760/cma.j.cn114798-20211221-00936
- VernacularTitle:腹膜透析患者骨骼肌减少症的诊治进展
- Author:
Jiaying WU
1
;
Shuijuan SHEN
;
Xiujuan WU
;
Jichao GUAN
;
Miaojia DING
Author Information
1. 绍兴文理学院医学院研究生院，绍兴312000
- Keywords:
Peritoneal dialysis;
Sarcopenia;
Diagnostic techniques and procedures;
Risk factors;
Forecasting
- From:
Chinese Journal of General Practitioners
2022;21(7):691-695
- CountryChina
- Language:Chinese
-
Abstract:
Sarcopenia is a systemic syndrome characterized by decreased muscle mass and muscle strength and decline of motor function.Sarcopenia affects quality of life and disease prognosis of patients seriously, because of the low awareness rate, low treatment rate and high cardiovascular risk. Patients with uremia undergoing peritoneal dialysis are likely to suffer from sarcopenia due to dietary restriction, loss of protein and high catabolism. This article summarizes the diagnostic methods, risk factors, predictive markers and intervention measures for sarcopenia in peritoneal dialysis patients.
